The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy
Abstract
PURPOSE: Partial nephrectomy for stage T1 renal cell carcinoma is oncologically efficacious and safe, and may have survival advantages. We describe our experience with partial nephrectomy for T2 or greater renal cell cancer. MATERIALS AND METHODS: Between 1970 and 2008 approximately 2,300 partial nephrectomies were done at our institution, including 69 for sporadic unilateral advanced stage tumors (pT2 in 32, pT3a in 28 and pT3b in 9). We reviewed outcomes in these patients compared to those in 207 treated with radical nephrectomy matched 3:1 for stage, tumor size, baseline renal function, age and gender. RESULTS: The risk of cancer specific (HR 0.80, 95% CI 0.43-1.50, p = 0.489) and overall (HR 1.11, 95% CI 0.72-1.71, p = 0.642) death was similar for partial nephrectomy. At a median of 3.2 years of followup 15 patients (22%) with partial nephrectomy had metastatic disease vs 69 (33%) with radical nephrectomy (HR 0.74, 95% CI 0.42-1.29, p = 0.29). Four patients (6%) with partial nephrectomy had isolated local recurrence vs 7 (3%) with radical nephrectomy (HR 2.11, 95% CI 0.62-7.22, p = 0.234). In the partial nephrectomy group 12 (17%) and 2 cases (3%) were complicated by urine leak and retroperitoneal bleeding requiring intervention, respectively. The median serum creatinine increase was 9.5% (IQR 0-22) vs 33% (IQR 20-47) for partial vs radical nephrectomy (p <0.001). CONCLUSIONS: Partial nephrectomy for T2 or greater renal cell carcinoma preserves renal function and appears to achieve oncological outcomes similar to those of radical nephrectomy. The role of partial nephrectomy in patients with T2-3 tumors and a normal contralateral kidney deserves further consideration and study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Cited by
Mir, M. C., Derweesh, I., Porpiglia, F., Zargar, H., Mottrie, A., & Autorino, R. (2017) · European Urology · doi:10.1016/j.eururo.2016.08.060 · Cited by 479
Kim, S. P., Thompson, R. H., Boorjian, S. A., Weight, C. J., Han, L. C., Murad, M. H., Shippee, N. D., Erwin, P. J., Costello, B. A., Chow, G. K., et al. (2012) · Journal of Urology · doi:10.1016/j.juro.2012.03.006 · Cited by 408
Self-citation
Metadata
- Authors
- Breau, R. H., Crispen, P. L., Jimenez, R. E., Lohse, C. M., Blute, M. L., & Leibovich, B. C.
- Venue
- Journal of Urology
- Published
- 2010-03
- Volume
- 183
- Issue
- 3
- Pages
- 903-908
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2019192689
- Cited by
- 161
- References
- 1
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy. https://app.cochat.ai/papers/10.1016/j.juro.2009.11.037
- The paper
- Breau, R. H., Crispen, P. L., Jimenez, R. E., Lohse, C. M., Blute, M. L., & Leibovich, B. C. (2010). Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy. Journal of Urology. https://doi.org/10.1016/j.juro.2009.11.037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.